OGT and cancer: At the physiological level, the FH S75A mutant significantly rescued the impaired xenograft tumor development resulted by OGT depletion, which indicates competition of OGT-mediated FH O-GlcNAcylation to FH Ser75 phosphorylation would be essential for cancer cell growth under condition of glucose deficiency in vivo.